Searchlight Pharma acquires Miravo Healthcare for C$91.4M
On March 14, 2023, Searchlight Pharma Inc. ("Searchlight") closed on the previously announced plan of arrangement to acquire Miravo Healthcare ("Miravo") for C$91.4 million. In connection with the Arrangement, Searchlight acquired 11,388,282 company shares, representing 100% of the issued and outstanding company shares, for cash consideration of $1.35 per company share. The Company Shares will be de-listed from the TSX and the Company will apply to cease to be a reporting issuer in each of the provinces of Canada.
Searchlight, headquartered in Montreal, is a leading Canadian-based specialty healthcare company that executes best-in-class search, acquisition, commercialization, and focused development of innovative and unique specialty healthcare products.
Miravo is a Canadian focused, healthcare company with global reach and a diversified portfolio of commercial products.
McCarthy Tétrault advised Searchlight with a team led by Clemens Mayr that included Deandra Schubert, Victoria de Luna, Richard O’Doherty, Eve Tessier, Mathilde Melancon-Brais, Janie Lambert-Roy and Quentin Pérès (Business).
